Mechanisms of pathogenesis: differences amongst Leishmania species.
about
Kinases as druggable targets in trypanosomatid protozoan parasitesChronic infection by Leishmania amazonensis mediated through MAPK ERK mechanismsNucleoside-diphosphate-kinase: a pleiotropic effector in microbial colonization under interdisciplinary characterizationSphingolipid degradation in Leishmania (Leishmania) amazonensisInfection with arginase-deficient Leishmania major reveals a parasite number-dependent and cytokine-independent regulation of host cellular arginase activity and disease pathogenesis.CD4+CD25+ regulatory T cells restrain pathogenic responses during Leishmania amazonensis infectionCross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasisIdentification of a compensatory mutant (lpg2-REV) of Leishmania major able to survive as amastigotes within macrophages without LPG2-dependent glycoconjugates and its significance to virulence and immunization strategiesDynamic of the cellular immune response at the dermal site of Leishmania (L.) amazonensis and Leishmania (V.) braziliensis infection in Sapajus apella primate.Leishmania infection impairs beta 1-integrin function and chemokine receptor expression in mononuclear phagocytes.Perforin and gamma interferon are critical CD8+ T-cell-mediated responses in vaccine-induced immunity against Leishmania amazonensis infection.Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensisEnhanced replication of Leishmania amazonensis amastigotes in gamma interferon-stimulated murine macrophages: implications for the pathogenesis of cutaneous leishmaniasis.Proteins Selected in Leishmania (Viannia) braziliensis by an Immunoproteomic Approach with Potential Serodiagnosis Applications for Tegumentary Leishmaniasis.CD4+ Th1 cells induced by dendritic cell-based immunotherapy in mice chronically infected with Leishmania amazonensis do not promote healingSand fly saliva enhances Leishmania amazonensis infection by modulating interleukin-10 production.Immunopathology of leishmaniasis: an update.Antileishmanial activity of the essential oil from Bixa orellana.Th1 cell development induced by cysteine proteinases A and B in localized cutaneous leishmaniasis due to Leishmania guyanensisVaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble Leishmania antigens and modified with a TNFα-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis.Leishmania (Viannia) panamensis: an in vitro assay using the expression of GFP for screening of antileishmanial drug.Leishmania major lacking arginase (ARG) are auxotrophic for polyamines but retain infectivity to susceptible BALB/c miceMolecular characterization of a human BRCA2 homolog in Leishmania donovaniDNA sequencing confirms the involvement of Leishmania (L.) amazonensis in American tegumentary leishmaniasis in the state of São Paulo, BrazilPrevious exposure to a low infectious dose of Leishmania major exacerbates infection with Leishmania infantum in the susceptible BALB/c mouse.The effects of induced diabetes and cutaneous Leishmania infection on the pharmacokinetics of antimony in hamsters.PD-L1 May Mediate T-Cell Exhaustion in a Case of Early Diffuse Leishmaniasis Caused by Leishmania (L.) amazonensis.
P2860
Q26786761-72AC53BA-9872-4C9D-BF29-CF4921806E3CQ26825223-67420271-0C6F-4735-9EA2-E40C3271D908Q26827519-783E8C24-2291-43CF-90EF-04383E8BEC03Q28484461-4EABA9CF-809E-414F-9327-68C54669B8B5Q33566856-93CDC677-FAA1-4FD3-8BE6-A8C6EDBDE8B1Q33614706-8CE7022F-B490-4833-8E38-48800F01AAF6Q33796005-2EB03C59-F691-4676-A09D-CDF87DABA6C5Q34147052-76EAC785-B65A-4A79-99B6-11A1D7707E66Q34176956-64247172-6494-4ECA-805F-A330385BF461Q34721081-330832CF-E1F2-41B7-A1BB-EE1E7370997FQ35011520-9F166D59-5C8D-4EA2-8C62-6B0A07FC2F5CQ35165095-D2913574-B2C7-4D42-A66E-00053CA79AC9Q35549173-CF330857-0364-4826-91F7-12F7204A79A3Q36211636-4B884560-AA31-44E4-8068-830FFF59E138Q36446351-BDD8F7B3-A11D-4D51-8805-D6AFBBA81019Q36576052-B2B7F154-8D59-4E2D-85EE-E2FF804C0A74Q36946047-63FB3731-ED25-4607-864A-63D2861755A9Q39264768-E0278766-35BA-49D2-A9AC-B8E6A6CFA6BFQ39746216-3935ED3D-9224-4A92-9749-7FC06D1E4226Q40061497-0FD4DA93-68E9-4DBC-9F51-F9194D1875F1Q40276020-507375BE-4B05-4331-8FB6-A8622CA2162DQ41858732-7CE12C3F-9573-4EC5-ABC9-CB031CAB1E7DQ41959303-CC27AC1A-2881-4BD4-A755-43546050C051Q42173728-CFA5597E-F095-47A8-AAFC-B32113D5B77DQ44218777-412487AF-190A-44EF-9861-384A434D2E8FQ51799532-112DFDC0-989A-417C-9A27-AD86731B2093Q54943471-60A7A7AE-EF9C-4A8D-88BE-1785E0A423CA
P2860
Mechanisms of pathogenesis: differences amongst Leishmania species.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Mechanisms of pathogenesis: differences amongst Leishmania species.
@ast
Mechanisms of pathogenesis: differences amongst Leishmania species.
@en
Mechanisms of pathogenesis: differences amongst Leishmania species.
@nl
type
label
Mechanisms of pathogenesis: differences amongst Leishmania species.
@ast
Mechanisms of pathogenesis: differences amongst Leishmania species.
@en
Mechanisms of pathogenesis: differences amongst Leishmania species.
@nl
prefLabel
Mechanisms of pathogenesis: differences amongst Leishmania species.
@ast
Mechanisms of pathogenesis: differences amongst Leishmania species.
@en
Mechanisms of pathogenesis: differences amongst Leishmania species.
@nl
P2093
P1476
Mechanisms of pathogenesis: differences amongst Leishmania species
@en
P2093
Diane McMahon-Pratt
Karen Goldsmith-Pestana
Sujata Kar
P356
10.1016/S0035-9203(02)90044-1
P478
96 Suppl 1
P577
2002-04-01T00:00:00Z